Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ADXN stock hub

Addex Therapeutics Ltd has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ADXNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ADXN

In the news

Latest news · ADXN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-87.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-22.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ADXN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

CHF

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001574232
Company name	Addex Therapeutics Ltd
Country	Switzerland
Country code	US
Cusip	00654J107
Employees	2
Employees Change	-21%
Employees Change Percent	-91.3
Enterprise value	$4.3M
Exchange	NASDAQ
Financial currency	CHF
First seen	2026-05-09
Industry	Biotechnology
Isin	US00654J2069
Last refreshed	2026-05-10
Market cap	$7.1M
Market cap category	Nano-Cap
Price	$6.84
Price currency	USD
Rev Per Employee	109,086.5x
Sector	Healthcare
Sic	2834
Symbol	ADXN
Website	https://www.addextherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-119.92%
EV/Sales	19.76x
P/B ratio	0.94x
P/S ratio	32.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$218,173
Net Income	$-8.5M
Net Income Growth Years	2%
Pretax Margin	-3,955.48%
Profit Per Employee	$-4.2M
Profitable Years	1
ROE	-87.53
Roe5y	-91.41
ROIC	-22.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-15.25%
Cagr3y	-22.23%
Cagr5y	-48.99%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth	-57.81x
Revenue Growth Q	959.02x
Revenue Growth Years	0x
Revenue Growth3 Y	-50.71x
Revenue Growth5 Y	-46.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	$2.8M
Debt	$46,092
Debt Equity	$0.01
Equity	$7.5M
Interest Coverage	-175.9
Net Cash	$2.7M
Net Cash By Market Cap	$38.33
Net Cash Growth	-34.82%
Net Debt Equity	$-0.36
Tangible Book Value	$7.5M
Tangible Book Value Per Share	$0.06
WACC	14.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.24%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-15.24%
200-day SMA	8.06
3Y total return	-52.97%
50-day SMA	6.72
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.55%
All Time High	750.4
All Time High Change	-99.09%
All Time High Date	2020-08-07
All Time Low	5
All Time Low Change	36.8%
All Time Low Date	2023-12-15
ATR	0.55
Beta	1.87
Ch YTD	-11.4
High	6.9
High52	12.05
High52 Date	2025-09-12
High52ch	-43.24%
Low	6.29
Low52	5.41
Low52 Date	2026-04-07
Low52ch	26.43%
Ma50ch	1.73%
Price vs 200-day SMA	-15.15%
RSI	50.68
RSI Monthly	35.7
RSI Weekly	43.84
Sharpe ratio	0.35x
Sortino ratio	0.6
Total Return	-16.24%
Tr YTD	-11.4
Tr1m	12.13%
Tr1w	-2.29%
Tr3m	-13.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-3.6M
Operating margin	-1,627.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	92,717,460%
Float Percent	64.12%
Shares Insiders	19.09%
Shares Institutions	2.14%
Shares Out	144,593,750
Shares Qo Q	28.33%
Shares Yo Y	16.24%
Short Ratio	1.34
Short Shares	0.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,711.45x
Bv Per Share	0.06
Ch1m	12.13
Ch1w	-2.29
Ch1y	-15.24
Ch3m	-13.42
Ch3y	-52.97
Ch5y	-96.55
Ch6m	-19.53
Change	-2.43%
Change From Open	-0.87
Close	7.01
Days Gap	-1.57
Depreciation Amortization	545.7
Dollar Volume	31,905.1
Earnings Date	2026-06-18
Earnings Time	bmo
EBIT	$-3.6M
EBITDA	$-3.5M
EPS	$-0.07
F Score	1
Fiscal Year End	December
Founded	2,002
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2025-12-31
Last Split Date	2023-10-23
Last Split Type	Reverse
Last10k Filing Date	2025-05-15
Ma150	7.9
Ma150ch	-13.38%
Ma20	6.84
Ma20ch	-0.01%
Next Earnings Date	2026-06-18
Open	6.9
Optionable	No
Position In Range	90.16
Price Date	2026-05-08
Ptbv Ratio	0.94
Relative Volume	0.82x
Revenue	218,173x
Tr6m	-19.53%
Volume	4,664.5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ADXN pay a dividend?

Capital-return profile for this ticker.

Performance

ADXN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ADXN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.1%

Float: +64.1% of shares outstanding

Insider ownership

+19.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ADXN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.7

Neutral momentum band

Price vs 200-day MA

-15.1%

50/200-day relationship not available

Beta (5Y)

1.86

More volatile than the market

Sharpe ratio

0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ADXN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ADXN stock rating?

Addex Therapeutics Ltd is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ADXN analysis?

The full report lives at /stocks/ADXN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ADXN?

The latest report frames ADXN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ADXN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.